statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

In trading on Thursday, shares of Kamada Ltd (KMDA) crossed below their 200 day moving average of 5.39, changing hands as low as 5.30 per share. Kamada Ltd shares are currently trading...

Kamada Breaks Below 200-Day Moving Average - Notable for KMDA

Kamada Ltd. (NASDAQ:KMDA  Free Report)  Research analysts at HC Wainwright decreased their FY2024 EPS estimates for shares of Kamada in a research note issued on Thursday, March 7th...

Brokers Offer Predictions for Kamada Ltd.'s FY2024 Earnings (NASDAQ:KMDA)

This price move could indicate a change in the trend, and may be a sell signal for investors...

Kamada (KMDA, $5.71) price exceeded its 50-day Moving Average on March 11, 2024

This is a Bearish indicator signaling KMDA's price could decline from here. Traders may explore shorting the stock or put options...

Kamada (KMDA, $6.03) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 6, 2024

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Kamada issues letter to shareholders

REHOVOT, Israel, and HOBOKEN, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed...

Kamada Issues 2024 CEO Letter to Shareholders

Total Revenues for Fiscal Year 2023 of $142.5 Million, Representing All-Time Record Annual Revenues and Up 10% Compared to Fiscal Year 2022Fiscal Year 2023 Adjusted EBITDA of $24.1 Million, Up 35...

Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability

Kamada Q4 2023 Earnings Preview

Kamada (NASDAQ:KMDA) anuncia su pr xima ronda de ganancias este mi rcoles, 06 de marzo. Esta es la gu a de Benzinga con la informaci n m s importante para esta presentaci n de resultados del cuarto...

Avance de ganancias: Kamada

Kamada (NASDAQ:KMDA) pubblicher i prossimi risultati degli utili questo mercoled 6 marzo. Ecco la guida essenziale di Benzinga per il rapporto sugli utili di Kamada per il quarto trimestre.
Utile...

Anteprima degli utili di Kamada

Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.

Volume	10,500.00
52-Wk High	$6.53
52-Wk Low	$4.08

KMDA Kamada Ltd

About

Feed

News

Sentiment

Earnings

Fundamentals